TY - JOUR
T1 - Mendelian randomization study highlights the role of hematological traits on Type-2 diabetes mellitus in African ancestry individuals
AU - Soremekun, Chisom
AU - Jjingo, Daudi
AU - Kateete, David
AU - Nash, Oyekanmi
AU - Nitsch, Dorothea
AU - Nyirenda, Moffat
AU - Gill, Dipender
AU - Zeggini, Eleftheria
AU - Grallert, Harald
AU - Peters, Annette
AU - Chikowore, Tinashe
AU - Batini, Chiara
AU - Soremekun, Opeyemi
AU - Fatumo, Segun
N1 - Publisher Copyright:
Copyright © 2025 Soremekun, Jjingo, Kateete, Nash, Nitsch, Nyirenda, Gill, Zeggini, Grallert, Peters, Chikowore, Batini, Soremekun and Fatumo.
PY - 2025
Y1 - 2025
N2 - Introduction: Observational studies have identified associations between hematological traits and type-2 diabetes mellitus (T2D). However, it is difficult to infer causal effects due to the potential of confounding. Our study utilizes the Mendelian randomization (MR) approach to address the above limitation and investigate the causal effect of hematological traits such as white blood cell (WBC), platelets (PLT), and red blood cell (RBC) on T2D in individuals of African ancestry. Methods: The participating cohorts included participants of African ancestry in the Blood Cell consortium and the Million Veteran Program dataset. Using GWAS summary statistics, we applied a univariable and multivariable Two-sample MR to estimate the causal relationship between hematological traits and T2D. Results: In the main IVW MR estimates, genetically predicted levels of mean corpuscular hemoglobin concentration (MCHC), mean corpuscular hemoglobin (MCH), and mean corpuscular volume (MCV) were associated with decreased risk of T2D. We also observed a decreased risk of T2D with genetically predicted total WBC count and neutrophil count (NEU), for the WBC traits. The multivariable analysis further supported the direct associations of genetically predicted MCH, MCHC, and MCV levels with a decreased risk of T2D. For the European ancestry, a similar pattern of association was observed for MCH and MCV. Discussion: These findings indicate that hematological traits may differentially play a role in the development of T2D and be affected by T2D. However, further research is needed to validate and explore the biological pathways and mechanisms involved in these associations.
AB - Introduction: Observational studies have identified associations between hematological traits and type-2 diabetes mellitus (T2D). However, it is difficult to infer causal effects due to the potential of confounding. Our study utilizes the Mendelian randomization (MR) approach to address the above limitation and investigate the causal effect of hematological traits such as white blood cell (WBC), platelets (PLT), and red blood cell (RBC) on T2D in individuals of African ancestry. Methods: The participating cohorts included participants of African ancestry in the Blood Cell consortium and the Million Veteran Program dataset. Using GWAS summary statistics, we applied a univariable and multivariable Two-sample MR to estimate the causal relationship between hematological traits and T2D. Results: In the main IVW MR estimates, genetically predicted levels of mean corpuscular hemoglobin concentration (MCHC), mean corpuscular hemoglobin (MCH), and mean corpuscular volume (MCV) were associated with decreased risk of T2D. We also observed a decreased risk of T2D with genetically predicted total WBC count and neutrophil count (NEU), for the WBC traits. The multivariable analysis further supported the direct associations of genetically predicted MCH, MCHC, and MCV levels with a decreased risk of T2D. For the European ancestry, a similar pattern of association was observed for MCH and MCV. Discussion: These findings indicate that hematological traits may differentially play a role in the development of T2D and be affected by T2D. However, further research is needed to validate and explore the biological pathways and mechanisms involved in these associations.
KW - Africa
KW - blood cell traits
KW - Hematological traits
KW - mendelian randomization
KW - Type-2 diabetes
UR - http://www.scopus.com/inward/record.url?scp=105002609910&partnerID=8YFLogxK
U2 - 10.3389/fphar.2025.1436972
DO - 10.3389/fphar.2025.1436972
M3 - Article
AN - SCOPUS:105002609910
SN - 1663-9812
VL - 16
JO - Frontiers in Pharmacology
JF - Frontiers in Pharmacology
M1 - 1436972
ER -